Induction of tolerance in hypersensitivity to mesalazine (5-ASA);Inducción de tolerancia en la hipersensibilidad a mesalazina (5-ASA)

Anales de Medicina Interna

Volumn 22, Issue 12, 2005, Pages 586-588

  Vázquez Fuertes, Laura ^a   Martinez Cocera C ^a   Robledo Echarren, T ^a   Dominguez Ortega J ^a   Gonzalez Gutierrez M L ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

5 aminosalicylic acid (5 ASA); Desensitization; Hypersensitivity; Mesalazine

Indexed keywords

ACETYLSALICYLIC ACID; BUDESONIDE; MESALAZINE; SALAZOPYRINA; SALAZOSULFAPYRIDINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANAMNESIS; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; DESENSITIZATION; DOSE RESPONSE; DRUG HYPERSENSITIVITY; DRUG TOLERANCE; ENTERITIS; HUMAN; MALE; PROVOCATION TEST; TREATMENT OUTCOME; URTICARIA; ADULT; CHEMICALLY INDUCED DISORDER;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; HUMANS; MALE; MESALAMINE; URTICARIA;

EID: 33644899967     PISSN: 02127199     EISSN: 02127199     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Vasundhara T. Sulfasalazine desensitization in children and adolescents with chronic inflammatory bowel disease. AJG 1992; 87 (8): 1029-1032.
2. Baker DE, Kane S. The Short- and Long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis. Rev Gastroenterol Disord 2004; 4:86-91.
3. Poldermans D, VanBlankenstein M. Pancreatitis induced by disodium azodisalicylate. Am J Gastroenterol 1988; 83: 578-580.
4. Ransford RAJ, Langmen MJS. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. Gut 2002; 51: 536-539.
5. Dreborg S, Frew A. Allergen standardization and skin tests. Position Paper EAACI subcommittee for allergen standardization and skin tests. Allergy 1993; 48 (Supl. 14): 49-82.
6. Turunen U, Elommaa I, Anttila VJ, Sëpäla K. Mesalazine tolerance in patients with inflammatory bowel disease and previous intolerance or alllergy to Sulphasalazine or Sulphonamides. Scand J Gastroenterol 1987; 22: 798-802.
7. Stelze RC, Squire EN. Oral desensitization to 5-aminosalicylic acid medications. Ann Allergy Asthma Innunol 1999; 83: 23-24.
8. Aparicio J, Carnicer F, Girona E. Cutaneous hypersensitivity reaction to mesalazine. Am J Gastroenterol 1996; 91: 620-1.
9. Fardy JM, Lloyd DA, Reynolds RP. Adverse effects with oral 5-aminosalicyclic acid. J Clin Gastroenterol 1988; 10: 635-7.
10. Le Gros V, Saveuse H, Lesur G, Brion N. Luna and skin hypersensitivity to 5-aminosalicylic acid. BMJ 1991; 302: 970.
11. Sigal Sviri. Gafanovich, I, Mordechai R.Mesalamine-induced hypersensitivity pneumonitis. J. Clinical Gastroenterology 1997; 24: 34-36.
12. Hautekeete M.L, Bourgeois N, Potvin P, et al. Hypersensitivity with hepatotoxicity to mesalazine after hypersensitivity to sulfasalazine. Gastroenterology 1992; 103: 1925-1927.
13. Gonzalo MA, Alcalde MM, García JM, Alvarado MI, Fernández L. Desensitization after fever induced by mesalazine. Allergy 1999; 54: 1224-1225.
14. Varela S, Díez MS, González C, González de la Cuesta C, Arenas L, Feijoo, Menéndez M. Oral desensitization to 5-ASA. Allergy 2002; 57: 371-372.
15. Smart BA, Adams CA, Lewis ST, Altman LC. Mesalamine desensitization for a patient with ulcerative colitis. Allergy Clin Immunol 1998; 101: S141.
16. Domínguez Ortega J, Martínez-Cócera C. RAM con salicilatos. A propósito de dos casos. Alergol Inmunol Clin 1998; 13 (Supl. 2): 198.